For the Quarter Ending September 2024
North America
In Q3 2024, the Tetradecane market in the USA observed a price increase of 5.09% from the previous quarter, reaching USD 1840/MT CFR-Texas, while remaining stable same quarter compared to a year ago. This upward trend can be attributed to strategic actions by manufacturers and suppliers, who effectively managed their inventory levels amid fluctuating demand conditions.
While crude oil prices saw a significant decline of 13.58% this quarter, along with a 6.58% decrease from the previous quarter, the impact on Tetradecane prices was mitigated by the strategic positioning of market participants. Suppliers capitalized on the stable demand in niche applications, allowing them to adjust their pricing strategies accordingly.
Additionally, the overall stability in Tetradecane prices over the past year indicates a resilient market sentiment, as producers navigate the challenges posed by external factors, including fluctuating feedstock costs. The combination of effective inventory management and sustained demand has reinforced a stable pricing environment, justifying the observed price increase amidst broader market dynamics.
APAC
In Q3 2024, the pricing landscape for Tetradecane in China exhibited a decrease of 3.43%, concluding the quarter at USD 1546/MT FOB Qingdao. This decline reflects moderate to low demand from key sectors, which has prompted manufacturers to adjust their pricing strategies accordingly. However, the market also experienced a 5.09% increase from the previous quarter, indicating a brief recovery phase before the recent price drop. This fluctuation can be attributed to the significant decrease in crude oil prices, which fell by 13.58% this quarter and 6.58% from the preceding quarter, impacting production costs and leading to more competitive pricing in the Tetradecane market. As suppliers grapple with the challenges posed by lower feedstock costs, their pricing actions have become increasingly strategic, focusing on maintaining market share amid subdued demand. Overall, while the recent decrease in Tetradecane prices is a response to fluctuating market dynamics and feedstock availability, the market remains stable compared to a year ago, suggesting a cautiously optimistic outlook as manufacturers adapt to ongoing economic conditions.
Europe
In Q3 2024, the pricing trend for Tetradecane in Europe saw a decrease compared to the previous quarter, while remaining stable compared to a year ago. This decline can be attributed to low sector performance driven by weak manufacturing activities and modest economic performance, which has adversely affected demand across various sectors. Market participants have adjusted their pricing strategies in response to these conditions, leading to a downward trend. Moreover, feedstock costs have also played a crucial role, as crude oil prices fell by 13.58% this quarter and 6.58% compared to the previous quarter. This reduction in crude oil prices has pressured producers to recalibrate their pricing models for Tetradecane, resulting in lower market prices. Despite the decline in pricing this quarter, the stability compared to the previous year suggests a resilient market environment amidst challenging conditions. As manufacturers navigate through the current economic landscape, the focus remains on managing inventory levels and adapting to the evolving market dynamics, positioning themselves for potential recovery as economic conditions improve in the future
